Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

USPH vs AFCG vs CCRN vs HCSG vs HIMS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$897M
5Y Perf.-43.3%
AFCG
Advanced Flower Capital Inc.

REIT - Specialty

Real EstateNASDAQ • US
Market Cap$73M
5Y Perf.-78.5%
CCRN
Cross Country Healthcare, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$423M
5Y Perf.+4.8%
HCSG
Healthcare Services Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.60B
5Y Perf.-20.4%
HIMS
Hims & Hers Health, Inc.

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$6.63B
5Y Perf.+94.0%

USPH vs AFCG vs CCRN vs HCSG vs HIMS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
USPH logoUSPH
AFCG logoAFCG
CCRN logoCCRN
HCSG logoHCSG
HIMS logoHIMS
IndustryMedical - Care FacilitiesREIT - SpecialtyMedical - Care FacilitiesMedical - Care FacilitiesMedical - Equipment & Services
Market Cap$897M$73M$423M$1.60B$6.63B
Revenue (TTM)$695M$6M$761M$1.84B$2.35B
Net Income (TTM)$11M$-20M$-99M$59M$128M
Gross Margin22.0%-76.6%18.2%13.3%69.7%
Operating Margin12.2%-124.7%-0.9%3.0%4.6%
Forward P/E20.6x133.8x20.8x51.5x
Total Debt$426M$76M$2M$25M$1.12B
Cash & Equiv.$36M$39M$109M$161M$229M

USPH vs AFCG vs CCRN vs HCSG vs HIMSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

USPH
AFCG
CCRN
HCSG
HIMS
StockMar 21May 26Return
U.S. Physical Thera… (USPH)10056.7-43.3%
Advanced Flower Cap… (AFCG)10021.5-78.5%
Cross Country Healt… (CCRN)100104.8+4.8%
Healthcare Services… (HCSG)10079.6-20.4%
Hims & Hers Health,… (HIMS)100194.0+94.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: USPH vs AFCG vs CCRN vs HCSG vs HIMS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: USPH and HCSG are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. Healthcare Services Group, Inc. is the stronger pick specifically for recent price momentum and sentiment and operational efficiency and capital deployment. HIMS and CCRN also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
USPH
U.S. Physical Therapy, Inc.
The Income Pick

USPH has the current edge in this matchup, primarily because of its strength in income & stability.

  • Dividend streak 5 yrs, beta 0.93, yield 3.1%
  • Lower P/E (20.6x vs 51.5x)
  • 3.1% yield, 5-year raise streak, vs AFCG's 28.1%, (3 stocks pay no dividend)
Best for: income & stability
AFCG
Advanced Flower Capital Inc.
The REIT Holding

Among these 5 stocks, AFCG doesn't own a clear edge in any measured category.

Best for: real estate exposure
CCRN
Cross Country Healthcare, Inc.
The Defensive Pick

CCRN is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 0.78, Low D/E 0.7%, current ratio 3.78x
  • Beta 0.78, current ratio 3.78x
  • Beta 0.78 vs HIMS's 2.40, lower leverage
Best for: sleep-well-at-night and defensive
HCSG
Healthcare Services Group, Inc.
The Momentum Pick

HCSG is the #2 pick in this set and the best alternative if momentum and efficiency is your priority.

  • +55.8% vs HIMS's -51.0%
  • 7.3% ROA vs CCRN's -19.8%, ROIC 9.0% vs -0.9%
Best for: momentum and efficiency
HIMS
Hims & Hers Health, Inc.
The Growth Play

HIMS ranks third and is worth considering specifically for growth exposure and long-term compounding.

  • Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
  • 161.9% 10Y total return vs USPH's 22.6%
  • 59.0% revenue growth vs AFCG's -39.6%
  • 5.5% margin vs AFCG's -333.9%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthHIMS logoHIMS59.0% revenue growth vs AFCG's -39.6%
ValueUSPH logoUSPHLower P/E (20.6x vs 51.5x)
Quality / MarginsHIMS logoHIMS5.5% margin vs AFCG's -333.9%
Stability / SafetyCCRN logoCCRNBeta 0.78 vs HIMS's 2.40, lower leverage
DividendsUSPH logoUSPH3.1% yield, 5-year raise streak, vs AFCG's 28.1%, (3 stocks pay no dividend)
Momentum (1Y)HCSG logoHCSG+55.8% vs HIMS's -51.0%
Efficiency (ROA)HCSG logoHCSG7.3% ROA vs CCRN's -19.8%, ROIC 9.0% vs -0.9%

USPH vs AFCG vs CCRN vs HCSG vs HIMS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M
AFCGAdvanced Flower Capital Inc.

Segment breakdown not available.

CCRNCross Country Healthcare, Inc.
FY 2025
Other Services
100.0%$30M
HCSGHealthcare Services Group, Inc.
FY 2025
Dietary Services
55.1%$1.0B
Environmental Services
44.9%$825M
HIMSHims & Hers Health, Inc.

Segment breakdown not available.

USPH vs AFCG vs CCRN vs HCSG vs HIMS — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHCSGLAGGINGCCRN

Income & Cash Flow (Last 12 Months)

Evenly matched — USPH and HIMS each lead in 2 of 6 comparable metrics.

HIMS is the larger business by revenue, generating $2.3B annually — 393.7x AFCG's $6M. HIMS is the more profitable business, keeping 5.5% of every revenue dollar as net income compared to AFCG's -3.3%. On growth, AFCG holds the edge at +64.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricUSPH logoUSPHU.S. Physical The…AFCG logoAFCGAdvanced Flower C…CCRN logoCCRNCross Country Hea…HCSG logoHCSGHealthcare Servic…HIMS logoHIMSHims & Hers Healt…
RevenueTrailing 12 months$695M$6M$761M$1.8B$2.3B
EBITDAEarnings before interest/tax$107M-$16M$9M$72M$164M
Net IncomeAfter-tax profit$11M-$20M-$99M$59M$128M
Free Cash FlowCash after capex$67M-$24M$41M$139M$73M
Gross MarginGross profit ÷ Revenue+22.0%-76.6%+18.2%+13.3%+69.7%
Operating MarginEBIT ÷ Revenue+12.2%-124.7%-0.9%+3.0%+4.6%
Net MarginNet income ÷ Revenue+1.5%-3.3%-13.0%+3.2%+5.5%
FCF MarginFCF ÷ Revenue+9.6%-3.9%+5.4%+7.6%+3.1%
Rev. Growth (YoY)Latest quarter vs prior year+7.7%+64.7%-100.0%+6.6%+28.4%
EPS Growth (YoY)Latest quarter vs prior year-115.0%+16.7%-6.0%+175.0%-27.3%
Evenly matched — USPH and HIMS each lead in 2 of 6 comparable metrics.

Valuation Metrics

Evenly matched — USPH and AFCG and CCRN each lead in 2 of 6 comparable metrics.

At 27.5x trailing earnings, HCSG trades at a 45% valuation discount to HIMS's 50.3x P/E. On an enterprise value basis, USPH's 12.5x EV/EBITDA is more attractive than HIMS's 42.7x.

MetricUSPH logoUSPHU.S. Physical The…AFCG logoAFCGAdvanced Flower C…CCRN logoCCRNCross Country Hea…HCSG logoHCSGHealthcare Servic…HIMS logoHIMSHims & Hers Healt…
Market CapShares × price$897M$73M$423M$1.6B$6.6B
Enterprise ValueMkt cap + debt − cash$1.3B$110M$317M$1.5B$7.5B
Trailing P/EPrice ÷ TTM EPS41.55x-3.25x-4.47x27.54x50.32x
Forward P/EPrice ÷ next-FY EPS est.20.63x133.84x20.83x51.51x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple12.52x23.75x22.38x42.68x
Price / SalesMarket cap ÷ Revenue1.15x2.32x0.40x0.87x2.82x
Price / BookPrice ÷ Book value/share1.16x0.39x1.31x3.19x12.25x
Price / FCFMarket cap ÷ FCF14.71x6.47x10.55x11.49x89.61x
Evenly matched — USPH and AFCG and CCRN each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

HCSG leads this category, winning 4 of 9 comparable metrics.

HIMS delivers a 23.7% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-27 for CCRN. CCRN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.07x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs HIMS's 4/9, reflecting strong financial health.

MetricUSPH logoUSPHU.S. Physical The…AFCG logoAFCGAdvanced Flower C…CCRN logoCCRNCross Country Hea…HCSG logoHCSGHealthcare Servic…HIMS logoHIMSHims & Hers Healt…
ROE (TTM)Return on equity+1.4%-11.1%-27.1%+11.8%+23.7%
ROA (TTM)Return on assets+0.9%-6.4%-19.8%+7.3%+6.0%
ROICReturn on invested capital+5.6%-4.1%-0.9%+9.0%+10.7%
ROCEReturn on capital employed+7.6%-5.6%-0.8%+7.7%+10.9%
Piotroski ScoreFundamental quality 0–954674
Debt / EquityFinancial leverage0.55x0.43x0.01x0.05x2.07x
Net DebtTotal debt minus cash$390M$38M-$106M-$136M$892M
Cash & Equiv.Liquid assets$36M$39M$109M$161M$229M
Total DebtShort + long-term debt$426M$76M$2M$25M$1.1B
Interest CoverageEBIT ÷ Interest expense15.42x-2.15x-1.39x33.02x
HCSG leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HIMS leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in HIMS five years ago would be worth $23,764 today (with dividends reinvested), compared to $5,539 for AFCG. Over the past 12 months, HCSG leads with a +55.8% total return vs HIMS's -51.0%. The 3-year compound annual growth rate (CAGR) favors HIMS at 29.4% vs CCRN's -17.7% — a key indicator of consistent wealth creation.

MetricUSPH logoUSPHU.S. Physical The…AFCG logoAFCGAdvanced Flower C…CCRN logoCCRNCross Country Hea…HCSG logoHCSGHealthcare Servic…HIMS logoHIMSHims & Hers Healt…
YTD ReturnYear-to-date-24.6%+10.2%+62.4%+28.6%-23.2%
1-Year ReturnPast 12 months-14.3%-35.5%-5.4%+55.8%-51.0%
3-Year ReturnCumulative with dividends-43.7%-20.1%-44.3%+48.6%+116.6%
5-Year ReturnCumulative with dividends-43.4%-44.6%-22.5%-21.1%+137.6%
10-Year ReturnCumulative with dividends+22.6%-42.4%-10.5%-26.8%+161.9%
CAGR (3Y)Annualised 3-year return-17.4%-7.2%-17.7%+14.1%+29.4%
HIMS leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CCRN and HCSG each lead in 1 of 2 comparable metrics.

CCRN is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than HIMS's 2.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 91.5% from its 52-week high vs HIMS's 36.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricUSPH logoUSPHU.S. Physical The…AFCG logoAFCGAdvanced Flower C…CCRN logoCCRNCross Country Hea…HCSG logoHCSGHealthcare Servic…HIMS logoHIMSHims & Hers Healt…
Beta (5Y)Sensitivity to S&P 5000.93x1.86x0.78x1.12x2.40x
52-Week HighHighest price in past year$93.50$5.87$14.99$24.39$70.43
52-Week LowLowest price in past year$58.55$2.06$7.43$12.66$13.74
% of 52W HighCurrent price vs 52-week peak+63.1%+52.6%+87.3%+91.5%+36.4%
RSI (14)Momentum oscillator 0–10046.148.253.161.854.5
Avg Volume (50D)Average daily shares traded171K235K552K676K34.9M
Evenly matched — CCRN and HCSG each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — AFCG and HCSG each lead in 1 of 2 comparable metrics.

Analyst consensus: USPH as "Buy", CCRN as "Hold", HCSG as "Hold", HIMS as "Hold". Consensus price targets imply 72.9% upside for USPH (target: $102) vs -18.9% for CCRN (target: $11). For income investors, AFCG offers the higher dividend yield at 28.10% vs USPH's 3.06%.

MetricUSPH logoUSPHU.S. Physical The…AFCG logoAFCGAdvanced Flower C…CCRN logoCCRNCross Country Hea…HCSG logoHCSGHealthcare Servic…HIMS logoHIMSHims & Hers Healt…
Analyst RatingConsensus buy/hold/sellBuyHoldHoldHold
Price TargetConsensus 12-month target$102.00$10.61$24.50$29.67
# AnalystsCovering analysts12141519
Dividend YieldAnnual dividend ÷ price+3.1%+28.1%
Dividend StreakConsecutive years of raises50120
Dividend / ShareAnnual DPS$1.80$0.87
Buyback YieldShare repurchases ÷ mkt cap+0.6%0.0%+1.6%+3.9%+1.4%
Evenly matched — AFCG and HCSG each lead in 1 of 2 comparable metrics.
Key Takeaway

HCSG leads in 1 of 6 categories (Profitability & Efficiency). HIMS leads in 1 (Total Returns). 4 tied.

Best OverallHealthcare Services Group, … (HCSG)Leads 1 of 6 categories
Loading custom metrics...

USPH vs AFCG vs CCRN vs HCSG vs HIMS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is USPH or AFCG or CCRN or HCSG or HIMS a better buy right now?

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -39. 6% for Advanced Flower Capital Inc. (AFCG). Healthcare Services Group, Inc. (HCSG) offers the better valuation at 27. 5x trailing P/E (20. 8x forward), making it the more compelling value choice. Analysts rate U. S. Physical Therapy, Inc. (USPH) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — USPH or AFCG or CCRN or HCSG or HIMS?

On trailing P/E, Healthcare Services Group, Inc.

(HCSG) is the cheapest at 27. 5x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, U. S. Physical Therapy, Inc. is actually cheaper at 20. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — USPH or AFCG or CCRN or HCSG or HIMS?

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -44. 6% for Advanced Flower Capital Inc. (AFCG). Over 10 years, the gap is even starker: HIMS returned +161. 9% versus AFCG's -42. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — USPH or AFCG or CCRN or HCSG or HIMS?

By beta (market sensitivity over 5 years), Cross Country Healthcare, Inc.

(CCRN) is the lower-risk stock at 0. 78β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 209% more volatile than CCRN relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — USPH or AFCG or CCRN or HCSG or HIMS?

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -39. 6% for Advanced Flower Capital Inc. (AFCG). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — USPH or AFCG or CCRN or HCSG or HIMS?

Hims & Hers Health, Inc.

(HIMS) is the more profitable company, earning 5. 5% net margin versus -66. 0% for Advanced Flower Capital Inc. — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USPH leads at 10. 3% versus -43. 6% for AFCG. At the gross margin level — before operating expenses — AFCG leads at 90. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is USPH or AFCG or CCRN or HCSG or HIMS more undervalued right now?

On forward earnings alone, U.

S. Physical Therapy, Inc. (USPH) trades at 20. 6x forward P/E versus 133. 8x for Cross Country Healthcare, Inc. — 113. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 72. 9% to $102. 00.

08

Which pays a better dividend — USPH or AFCG or CCRN or HCSG or HIMS?

In this comparison, AFCG (28.

1% yield), USPH (3. 1% yield) pay a dividend. CCRN, HCSG, HIMS do not pay a meaningful dividend and should not be held primarily for income.

09

Is USPH or AFCG or CCRN or HCSG or HIMS better for a retirement portfolio?

For long-horizon retirement investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93), 3. 1% yield). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (USPH: +22. 6%, HIMS: +161. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between USPH and AFCG and CCRN and HCSG and HIMS?

These companies operate in different sectors (USPH (Healthcare) and AFCG (Real Estate) and CCRN (Healthcare) and HCSG (Healthcare) and HIMS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: USPH is a small-cap high-growth stock; AFCG is a small-cap income-oriented stock; CCRN is a small-cap quality compounder stock; HCSG is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock. USPH, AFCG pay a dividend while CCRN, HCSG, HIMS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Stocks Like

AFCG

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 32%
  • Dividend Yield > 11.2%
Run This Screen
Stocks Like

CCRN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

HCSG

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
Run This Screen
Stocks Like

HIMS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform USPH and AFCG and CCRN and HCSG and HIMS on the metrics below

Revenue Growth>
%
(USPH: 7.7% · AFCG: 64.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.